Results 221 to 230 of about 30,962 (267)

Primary prevention for patients with intermediate framingham Risk Scores

Current Cardiology Reports, 2006
Coronary heart disease (CHD) is the leading cause of mortality in the industrialized world. Proper identification of individuals at risk for CHD is challenging. The Framingham Risk Score, the most widely accepted tool for quantifying 10-year risk, fails to identify a great proportion of future CHD. Because of the health and economic consequences of CHD,
Jason B, Thompson, Juan J, Rivera, Roger S, Blumenthal, Peter, Danyi   +3 more
openaire   +2 more sources

Assessing Predictive Performance Beyond the Framingham Risk Score

JAMA, 2010
_To the Editor:_ According to the review by Dr Tzoulaki and colleagues, most studies that claimed improved predictive performance beyond the Framingham risk score (FRS) had flaws in their design, analyses, and reporting. To interpret these observations, 2 questions are pertinent: what did the original studies aim to investigate, and what ...
Ferket, Bart, van Kempen, Bob, Janssens, Cecile   +2 more
openaire   +3 more sources

Framingham risk score and severity of coronary artery disease

Herz, 2013
Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide. Easy-to-perform and reliable parameters are needed to predict the presence and severity of CAD and to implement efficient diagnostic and therapeutic modalities. We aimed to examine whether the Framingham risk scoring system can be used for this purpose.A total of 222 
M.A. Kurcer, Mehmet Ali Çetiner, Sait Mesut Dogan, Turgut Karabag, Muhammet Rasit Sayin, E. Sayin, Ibrahim Akpinar, Mustafa Aydin   +7 more
openaire   +3 more sources

Discordance between Framingham Risk Score and atherosclerotic plaque burden

European Heart Journal, 2013
Clinical predictors are routinely used to identify individuals who may benefit from aggressive risk factor modification. However, clinical predictors cannot account for all genetic and environmental variables. The objective of this study is to investigate the association of Framingham Risk Score (FRS) with computed tomography angiography (CTA) measures
Ally, Pen, Yeung, Yam, Li, Chen, Carole, Dennie, Ruth, McPherson, Benjamin J W, Chow   +5 more
openaire   +2 more sources

Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus

The Journal of Rheumatology, 2016
Objective.The traditional Framingham Risk Factor Score (FRS) underestimates the risk for coronary artery disease (CAD) in patients with systemic lupus erythematosus (SLE). We aimed to determine whether an adjustment to the FRS would more accurately reflect the higher prevalence of CAD among patients with SLE.Methods.Patients with SLE without a previous
Murray B, Urowitz, Dominique, Ibañez, Jiandong, Su, Dafna D, Gladman   +3 more
openaire   +2 more sources

Relationship between lower urinary tract symptoms and cardiovascular risk scores including Framingham risk score and ACC/AHA risk score

Neurourology and Urodynamics, 2017
Aims This study attempted to investigate the association between lower urinary tract symptoms (LUTS) and cardiovascular disease (CVD) risk using International Prostate Symptom Score (IPSS) and CVD risk scores and to overcome the limitations of previous relevant studies.
Bora Lee, Sang Wook Lee, Hye Rim Kang, Dae In Kim, Hwa Yeon Sun, Jae Heon Kim   +5 more
openaire   +2 more sources

Kidney Disease, Framingham Risk Scores, and Cardiac and Mortality Outcomes

The American Journal of Medicine, 2007
The Framingham equations were developed to predict incident coronary heart disease. It remains unknown how the presence of chronic kidney disease affects their performance.Individuals without preexisting cardiovascular disease aged 45 to 74 years from the Atherosclerosis Risk in Communities and Cardiovascular Health Studies were analyzed.
Daniel E, Weiner, Hocine, Tighiouart, John L, Griffith, Essam, Elsayed, Andrew S, Levey, Deeb N, Salem, Mark J, Sarnak   +6 more
openaire   +2 more sources

The Framingham risk score is valuable in Europeans

Nature Reviews Nephrology, 2010
The Framingham hypertension risk score developed in the US has been validated in a large group of London-based civil servants. The score is therefore a useful tool for estimating the short-term risk of developing hypertension in a European population.
openaire   +1 more source

Performance of the Framingham Risk Score in patients receiving hemodialysis

Nephrology, 2013
AbstractAimThe Framingham Risk Score (FRS), calculated by considering conventional risk factors of cardiovascular diseases, was developed to predict coronary heart disease in various populations. However, reverse epidemiology has been raised concerning these risk factors in predicting high cardiovascular mortality in hemodialysis patients.
Jiun-Chi, Huang, Szu-Chia, Chen, Ho-Ming, Su, Jer-Ming, Chang, Shang-Jyh, Hwang, Hung-Chun, Chen   +5 more
openaire   +2 more sources

Raloxifene and Risk for Stroke Based on the Framingham Stroke Risk Score

The American Journal of Medicine, 2009
Raloxifene reduces vertebral fracture and invasive breast cancer risks, but increases fatal strokes in postmenopausal women at increased coronary risk. We assessed whether this risk is concentrated in postmenopausal women already at high stroke risk.Raloxifene Use for The Heart (RUTH) enrolled 10,101 postmenopausal women (mean age 67 years) with or at ...
Elizabeth, Barrett-Connor, David A, Cox, Jingli, Song, Bruce, Mitlak, Lori, Mosca, Deborah, Grady   +5 more
openaire   +2 more sources